What Does GLP-1 Medical Weight Loss Cost in Fort Collins?

As of mid-2026, here is what the medication alone costs a cash-pay patient, according to the manufacturers and national reporting:

Brand-name tirzepatide (Zepbound®) — $299–$449 per month in self-pay vials through Eli Lilly's direct program, depending on dose, as reported by CNBC when the federal pricing deals were announced in November 2025.

Brand-name semaglutide (Wegovy®) — about $349 per month self-pay through Novo Nordisk's pharmacy program, with introductory pricing near $199 for starting doses, per the same CNBC reporting.

Orforglipron (Foundayo®), the first GLP-1 pill approved for weight loss (April 2026) — self-pay from $149 per month for the lowest dose, per Eli Lilly's approval announcement.

TrumpRx, the federal cash-pay platform launched in January 2026, lists semaglutide and tirzepatide near $350 per month, as reported by AJMC.

Medicare begins covering these medications for weight management in mid-2026, with out-of-pocket costs around $50 per month for eligible beneficiaries, according to Kiplinger's Medicare explainer.

Every figure above is the price of the drug alone. It does not include the medical evaluation, lab work, or ongoing supervision that safe treatment requires — more on that below.

Three things collapsed the cash price of GLP-1 medication between late 2025 and mid-2026:

1. Most-favored-nation pricing deals — In November 2025, both major manufacturers agreed with the federal government to bring U.S. prices closer to what other countries pay, cutting list prices that had exceeded $1,000 per month.

2. Direct-to-patient programs — The manufacturers now sell directly to cash-pay patients, bypassing pharmacy middlemen. That is where the $149–$449 monthly prices come from.

3. The first GLP-1 pill — Orforglipron's approval in April 2026 added an oral option priced below most injections, putting price pressure on the whole category.

If you priced GLP-1 treatment in 2024 and walked away from four-figure numbers, the landscape genuinely changed.

Insurance is where most cost surprises happen, because coverage for weight loss specifically is far from universal:

Employer plans — In the KFF 2025 Employer Health Benefits Survey, only 16% of firms with 200–999 workers covered GLP-1s primarily for weight loss. Coverage rises with company size — 30% at 1,000–4,999 workers and 43% at 5,000 or more — but Northern Colorado employment skews toward the smaller end of that scale.

Coverage is tightening, not loosening — 59% of the largest employers covering GLP-1s told KFF that usage ran higher than expected, and two-thirds said the drugs had a significant impact on their pharmacy spending.

Insurance doesn't guarantee affordability — In KFF's national tracking poll, 55% of insured GLP-1 users said the drugs were difficult to afford, and 27% of users with insurance paid the full cost out of pocket.

Health First Colorado (Colorado's Medicaid program) covers GLP-1 medications for type 2 diabetes but does not cover them for weight loss, per the state's pharmacy benefit coverage policy (Appendix P).

Medicare's obesity coverage begins July 2026 for eligible beneficiaries, as noted above — a major change, since Medicare was previously barred from covering weight loss medication.

The practical takeaway: check your specific plan before assuming coverage either way, and budget as if you may be self-pay.

Compounded GLP-1s — versions made by compounding pharmacies rather than the original manufacturers — boomed during the 2022–2025 drug shortages, often at a fraction of the then-$1,000+ brand prices. That era is closing.

On April 30, 2026, the FDA proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the list that allows large-scale compounding, finding no clinical need now that the approved drugs are available. The public comment period closed June 29, 2026, and a final decision is expected later in the year.

Traditional pharmacies can still fill patient-specific compounded prescriptions, but only where a provider documents a clinical reason the approved product doesn't fit — an allergy to an inactive ingredient, for example, or a dosage form that isn't commercially made. Regulators have been explicit that a lower price is not a qualifying reason, and they are scrutinizing workarounds like adding vitamins to relabel a copy as 'personalized.'

At Peak Medical Wellness, which medication you take — and in what form — is a clinical decision made with your provider at an in-person evaluation, within whatever current regulations allow. Cost matters, but it's the last input, not the first.

When you compare clinics — or clinics versus subscription apps — the medication is only one line item. Four things drive the rest:

Lab work — A legitimate medical program starts with baseline labs (metabolic panel, A1c, lipids, thyroid) and rechecks key markers as you progress. Labs are how your provider catches problems early and doses accurately.

Visit cadence — An in-person evaluation up front, then regular follow-ups. More clinical contact costs more than a chatbot renewal — it's also what keeps treatment working when weight plateaus or side effects appear.

Medication type, dose, and route — Injectable versus oral, starting dose versus maintenance, and how your dose changes over time all move the monthly number.

Monitoring and adjustments — Dose changes, side-effect management, and plan updates between visits. This is the part that separates supervised treatment from a subscription.

Our Fort Collins medical weight loss program is built around those four pieces — provider evaluation, labs, personalized dosing, and follow-up — rather than around any single medication.

Roughly one in eight U.S. adults now takes a GLP-1 medication, per KFF polling — these drugs have gone mainstream, and the medication itself is quickly becoming the commodity part of treatment.

What still varies enormously is everything around the drug: whether anyone checked your labs before you started, who notices when your dose needs to change, what happens when side effects show up, and whether your plan accounts for the rest of your health.

Some people do fine buying medication directly and managing on their own. A medical program exists for everyone else — people with other conditions in the mix, people who've regained weight after previous attempts, and people who want a clinician accountable for the outcome.

When you compare costs, compare the whole package: medication plus labs plus visits plus monitoring — not just the headline drug price.